Akèy › Kolit Ulseratif › Massachusetts
Etid klinik pou Kolit Ulseratif nan Massachusetts
17 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan Massachusetts.
Vil nan Massachusetts
Tèks ofisyèl etid la (Anglè)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Lucida Clinical Trials /ID# 282000, New Bedford
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health Research - Framingham, Framingham
- Lucida Clinical Trials LLC, New Bedford
Ap rekriteFaz 4
Laj 18 a 80 · Tout sèks · Mizajou Sep 30, 2026 · NCT06581328A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 003, Boston
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07012395A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Boston Children's Hospital, Boston
- University of Massachusetts Chan Medical School, Worcester
Ap rekriteFaz 2/3
Laj 2 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Lucida Clinical Trials, New Bedford
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Boston Children's Hospital, Boston
- Massachusetts General Hospital, Waltham
Ap rekriteFaz 3
Laj 2 a 19 · Tout sèks · Mizajou Sep 22, 2026 · NCT04844606LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Brigham and Women's Hospital, Boston
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07186101An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Tufts Medical Center - Site Number: 8400126, Boston
- UMass Memorial Medical Center - Site Number: 8400121, Worcester
Ap rekriteFaz 3
Laj 16 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT07184996Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Brigham and Women's Hospital, Boston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07237516Treatment of UC With Novel Therapeutics
- Brigham and Women's Hospital, Chestnut Hill
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jul 21, 2026 · NCT06420375A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Boston Children's Hospital, Boston
Ap rekriteFaz 2
Laj 12 a 17 · Tout sèks · Mizajou Jul 8, 2026 · NCT05287126A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400017, Boston
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Apr 23, 2026 · NCT06975722Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Massachusetts General Hospital, Boston
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Jan 8, 2026 · NCT05987852Study of Novel Therapeutics for Acute Remedy of Colitis
- Brigham and Women's Hospital, Chestnut Hill
- Brigham and Women's Hospital, Chestnut Hill
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Oct 20, 2025 · NCT06420492High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
- Boston Children's Hospital, Boston
Ap rekriteEtid obsèvasyon
Laj 5 a 25 · Tout sèks · Mizajou Mar 3, 2025 · NCT04331639Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
- Massachusetts General Hospital, Boston
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 14 ak plis · Tout sèks · Mizajou Dec 20, 2024 · NCT06655415Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.